Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

被引:571
作者
Hunsicker, LG [1 ]
Adler, S [1 ]
Caggiula, A [1 ]
England, BK [1 ]
Greene, T [1 ]
Kusek, JW [1 ]
Rogers, NL [1 ]
Teschan, PE [1 ]
机构
[1] NIDDKD, NIH, BETHESDA, MD 20892 USA
关键词
D O I
10.1038/ki.1997.260
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The Modification of Diet in Renal Disease (MDRD) Study examined the effects of dietary protein restriction and strict blood pressure control on the decline in glomerular filtration rate (GFR) in 840 patients with diverse renal diseases. We describe a systematic analysis to determine baseline factors that predict the decline in GFR, or which alter the efficacy of the diet or blood pressure interventions. Univariate analysis identified 18 of 41 investigated baseline factors as significant (P < 0.05) predictors of GFR decline. In multivariate analysis, six factors-greater urine protein excretion, diagnosis of polycystic kidney disease (PKD), lower serum transferrin, higher mean arterial pressure, black race, and lower serum HDL cholesterol-independently predicted a faster decline in GFR. Together with the study interventions, these six factors accounted for 34.5% and 33.9% of the variance between patients in GFR slopes in Studies A and B, respectively, with proteinuria and PKD playing the predominant role. The mean rate of GFR decline was not significantly related to baseline GFR, suggesting an approximately linear mean GFR decline as renal disease progresses. The 41 baseline predictors were also assessed for their interactions with the diet and blood pressure interventions. A greater benefit of the low blood pressure intervention was found in patients with higher baseline urine protein. None of the 41 baseline factors were shown to predict a greater or lesser effect of dietary protein restriction.
引用
收藏
页码:1908 / 1919
页数:12
相关论文
共 35 条
  • [1] DESIGN AND STATISTICAL ISSUES OF THE MODIFICATION OF DIET IN RENAL-DISEASE TRIAL
    BECK, GJ
    BERG, RL
    COGGINS, CH
    GASSMAN, JJ
    HUNSICKER, LG
    SCHLUCHTER, MD
    WILLIAMS, GW
    [J]. CONTROLLED CLINICAL TRIALS, 1991, 12 (05): : 566 - 586
  • [2] PROGRESSION OF RENAL-INSUFFICIENCY - ROLE OF BLOOD-PRESSURE
    BRAZY, PC
    STEAD, WW
    FITZWILLIAM, JF
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (02) : 670 - 674
  • [3] CAMERON JS, 1990, AM J NEPHROL, V10, P81
  • [4] Chambers JM., 1983, WADSWORTH
  • [5] DAMICO G, 1991, AM J KIDNEY DIS, V17, P48
  • [6] Effron B, 1993, INTRO BOOTSTRAP
  • [7] ETHNICITY AND RENAL-DISEASE - LESSONS FROM THE MULTIPLE RISK FACTOR INTERVENTION TRIAL AND THE TREATMENT OF MILD HYPERTENSION STUDY
    FLACK, JM
    NEATON, JD
    DANIELS, B
    ESUNGE, P
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (04) : 31 - 40
  • [8] GREENE T, 1993, J AM SOC NEPHROL, V3, P1819
  • [9] GREENE T, 1993, J AM SOC NEPHROL, V4, P1221
  • [10] HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315